Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Katia MC Verhamme (Rotterdam, Netherlands), Katia M.C. Verhamme, Ulrike Goditiabois, Marjolein Engelkes, Miriam Sturkenboom, Bruno Stricker, Guy Brusselle. Use of β-blockers and the risk of asthma exacerbations. Eur Respir J 2016; 48: Suppl. 60, 1795

Member's Comments

No comment yet.

Related content which might interest you: Serious asthma exacerbations in a hospital setting Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Sesonal variations of severe asthma exacerbations in the US Source: International Congress 2014 – Risk factors for respiratory disease Year: 2014 Predictors of exacerbations in asthma Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Characterization of asthma exacerbations in outpatients – National survey Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Acute exacerbations of asthma in Barcelona, the recent experience Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013 Identifying patients at risk for future exacerbations of asthma: Development of a prediction model Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Guideline adherence and cost of asthma treatment at emergency department Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Experience with omalizumab in patients with moderate and severe asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 Use of a standardized order set in the management of an acute exacerbation of COPD Source: International Congress 2014 – Markers Year: 2014 Detection of asthma patient-reported exacerbations during follow-up in the ASTROLAB cohort Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Factors related with hospitalizations due to asthma exacerbations Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Safety and tolerability of acute dosing of beta-blockers in asthma Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Asthma control, symptoms and exacerbations across treatment levels in patients with asthma Source: Annual Congress 2013 –Management of respiratory diseases in primary care Year: 2013 Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Occupational asthma as a result of severe asthma Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 Combined therapy of asthma and allergic rhinitis Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Elevated blood eosinophil is a risk factor for future exacerbations in asthmatic children Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014